ACHV · Achieve Life Sciences, Inc.
Market Cap
$873.64M
Shares
102.90M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-14 | — | |
| 10-Q | 2026-08-11 | 2026-06-30 | |
| 8-K | 2026-08-11 | — | |
| 8-K | 2026-07-06 | 2026-07-02 | |
| DEF 14A | 2026-06-08 | — | |
| 8-K | 2026-06-02 | 2026-05-29 | |
| 8-K | 2026-05-12 | 2026-05-07 | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| 10-K/A | 2026-04-30 | 2025-12-31 | |
| 8-K | 2026-04-16 | 2026-04-15 | |
| 10-K | 2026-03-24 | 2025-12-31 | |
| 8-K | 2026-03-24 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-10-07 | 2025-10-06 | |
| 8-K | 2025-09-11 | 2025-09-05 | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-08-07 | — | |
| 8-K | 2025-06-27 | 2025-06-26 | |
| 8-K | 2025-06-06 | 2025-06-04 | |
| 8-K | 2025-05-13 | — | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| DEF 14A | 2025-04-28 | — | |
| 8-K | 2025-03-11 | — | |
| 10-K | 2025-03-11 | 2024-12-31 | |
| 8-K | 2025-02-10 | — | |
| 8-K | 2025-01-10 | 2025-01-06 | |
| 8-K | 2024-12-09 | 2024-12-05 | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-11-07 | — | |
| 8-K | 2024-09-27 | — | |
| 8-K | 2024-08-26 | 2024-08-20 | |
| 8-K | 2024-08-13 | — | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-07-29 | 2024-07-25 | |
| 8-K | 2024-06-27 | — | |
| 8-K | 2024-06-06 | 2024-06-05 | |
| 8-K | 2024-05-09 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| DEF 14A | 2024-04-26 | 2024-06-05 | |
| 8-K | 2024-03-28 | — | |
| 10-K | 2024-03-28 | 2023-12-31 | |
| 8-K | 2024-02-29 | 2024-02-28 | |
| 8-K | 2023-12-11 | — | |
| 8-K | 2023-11-09 | — | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 8-K | 2023-08-14 | — | |
| 10-Q | 2023-08-14 | 2023-06-30 | |
| 8-K | 2023-06-09 | 2023-06-07 | |
| 8-K | 2023-05-25 | — |
Showing 1–50 of 106 filings
Key facts
CIK
949858
CUSIP
004468500
13F (30d)
90 filings
90 filers
Visit website
Investor relations